BMCAX
Price
$23.58
Change
-$0.83 (-3.40%)
Updated
Dec 18 closing price
RGAAX
Price
$65.71
Change
-$9.05 (-12.11%)
Updated
Dec 18 closing price
Ad is loading...

BMCAX vs RGAAX

Header iconBMCAX vs RGAAX Comparison
Open Charts BMCAX vs RGAAXBanner chart's image
BlackRock Advantage Large Cap Gr Inv A
Price$23.58
Change-$0.83 (-3.40%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R1
Price$65.71
Change-$9.05 (-12.11%)
VolumeN/A
CapitalizationN/A
BMCAX vs RGAAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMCAX vs. RGAAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMCAX is a StrongBuy and RGAAX is a Buy.

FUNDAMENTALS
Fundamentals
RGAAX has more cash in the bank: 313B vs. BMCAX (1.44B). BMCAX pays higher dividends than RGAAX: BMCAX (0.04) vs RGAAX (0.00). BMCAX was incepted earlier than RGAAX: BMCAX (38 years) vs RGAAX (23 years). BMCAX is a more actively managed with annual turnover of: 130.00 vs. RGAAX (31.00). RGAAX has a lower initial minimum investment than BMCAX: RGAAX (250) vs BMCAX (1000). RGAAX annual gain was more profitable for investors over the last year : 34.27 vs. BMCAX (12.70). BMCAX (48.88) and RGAAX (47.92) have equivalent 5 years return.
BMCAXRGAAXBMCAX / RGAAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence38 years23 years-
Gain YTD11.97232.95436%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.44B313B0%
Annual Yield % from dividends0.040.00-
Returns for 1 year12.7034.2737%
Returns for 3 years11.7114.9678%
Returns for 5 years48.8847.92102%
Returns for 10 years76.6381.6394%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SWAG0.93N/A
+0.18%
Stran & Company
UTMD62.53-0.42
-0.67%
Utah Medical Products
RARE44.95-0.45
-0.99%
Ultragenyx Pharmaceutical
NWG10.23-0.20
-1.92%
NatWest Group plc
PFS20.19-0.47
-2.27%
Provident Financial Services